NanoSphere Health Sciences Inc. provided an update regarding its operations in Canada, along with its Canadian partner, Delta 9 Cannabis Inc,. The company announced that Delta 9 has filed a Notice of New Cannabis Product Application with Health Canada and will be proceeding to produce commercial batches of an ingestible cannabis oil using Nanosphere patented technology. Once produced, the initial commercial batches will require final review and approval by Delta 9 and Health Canada prior to being sold under the Delta 9 ­ Evolve brand in the Canadian Market.